A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto(TM)) treated vs. untreated dogs using the parameters tick weight and coxal index

BACKGROUND: Fluralaner is a new antiparasitic drug that was recently introduced as Bravecto(TM) chewable tablets for the treatment of tick and flea infestations in dogs. Most marketed tick products exert their effect via topical application and contact exposure to the parasite. In contrast, Bravecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Heike, Demeler, Janina, Taenzler, Janina, Roepke, Rainer K.A., Zschiesche, Eva, Heckeroth, Anja R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488133/
https://www.ncbi.nlm.nih.gov/pubmed/26123249
http://dx.doi.org/10.1186/s13071-015-0963-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488133/
https://www.ncbi.nlm.nih.gov/pubmed/26123249
http://dx.doi.org/10.1186/s13071-015-0963-6

Ejemplares similares